# Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

> **NCT06608433** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteer Study
- HPA
- Cortisol Deficiency
- Adrenal Insufficiency

## Interventions

- **DRUG:** semaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06608433
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-16
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-11-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06608433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06608433, "Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06608433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*